Validation of assays for measurement of amyloid-β peptides in cerebrospinal fluid and plasma specimens from patients with Alzheimer's disease treated with solanezumab. [electronic resource]
Producer: 20130912Description: 897-910 p. digitalISSN:- 1875-8908
- Alzheimer Disease -- blood
- Amyloid beta-Peptides -- blood
- Antibodies, Monoclonal, Humanized -- therapeutic use
- Antipsychotic Agents -- therapeutic use
- Biotinylation
- Calibration
- Enzyme-Linked Immunosorbent Assay
- Female
- Humans
- Linear Models
- Male
- Peptide Fragments -- blood
- Reference Values
- Reproducibility of Results
- Time Factors
No physical items for this record
Publication Type: Journal Article
There are no comments on this title.
Log in to your account to post a comment.